Notice of Correction of Review Locus for PAR-15-278 "NINDS Exploratory Clinical Trials for Small Business (R42)"

Notice Number: NOT-NS-15-049

Key Dates
Release Date: November 19, 2015

Related Announcements
PAR-15-278

Issued by
National Institute of Neurological Disorders and Stroke (NINDS)

Purpose

The purpose of this notice is to correct information regarding the locus of review for applications submitted to PAR-15-278 "NINDS Exploratory Clinical Trials for Small Business (R42)".

Part 2. Section V. 2. Review and Selection Process
FOA currently reads:
Applications will be evaluated for scientific and technical merit by (an) appropriate Scientific Review Group(s) convened by Center for Scientific Review, in accordance with NIH peer review policy and procedures, using the stated review criteria. Assignment to a Scientific Review Group will be shown in the eRA Commons.

FOA is modified to read:
Applications will be evaluated for scientific and technical merit by an appropriate Scientific Review Group(s) convened by NINDS, in accordance with NIH peer review policy and procedures, using the stated review criteria. Assignment to a Scientific Review Group will be shown in the eRA Commons.

Part 2. Section VII. Agency Contacts
FOA currently reads:

Peer Review Contact(s)

Joseph Rudolph, PhD
Center for Scientific Review (CSR)
Telephone: 301-408-9098
Email: [email protected]

FOA is modified to read:

Peer Review Contact(s)

Chief, Scientific Review Branch
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-9223
Email: [email protected]

All other aspects of the FOA remain unchanged

Inquiries

Please direct all inquiries to:

Stephanie Fertig, MBA
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-1779
Email: [email protected]